Cargando…

Current Flavivirus Research Important for Vaccine Development

Detalles Bibliográficos
Autores principales:	Geerling, Elizabeth, Steffen, Tara L., Brien, James D., Pinto, Amelia K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563144/ https://www.ncbi.nlm.nih.gov/pubmed/32867038 http://dx.doi.org/10.3390/vaccines8030477

Ejemplares similares

Recent Developments in Vaccines against Flaviviruses and Alphaviruses
por: Kim, Young Chan, et al.
Publicado: (2023)

Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection
por: Hassert, Mariah, et al.
Publicado: (2021)

Obesity Enhances Disease Severity in Female Mice Following West Nile Virus Infection
por: Geerling, Elizabeth, et al.
Publicado: (2021)

Flavivirus vaccines: Innovate, invest, implement
Publicado: (2016)

Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells
por: Hassert, Mariah, et al.
Publicado: (2019)

Infection order outweighs the role of CD4(+) T cells in tertiary flavivirus exposure
por: Marzan-Rivera, Nicole, et al.
Publicado: (2022)

Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus
por: Steffen, Tara, et al.
Publicado: (2020)

T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology
por: Stone, E. Taylor, et al.
Publicado: (2023)

A Perspective on Current Flavivirus Vaccine Development: A Brief Review
por: Dutta, Sudip Kumar, et al.
Publicado: (2023)

Prioritizing the ‘Dormant’ Flaviviruses
por: Olival, Kevin J., et al.
Publicado: (2017)

Flavivirus NS1 and Its Potential in Vaccine Development
por: Carpio, Kassandra L., et al.
Publicado: (2021)

Metabolic syndrome and aberrant immune responses to viral infection and vaccination: Insights from small animal models
por: Geerling, Elizabeth, et al.
Publicado: (2022)

Impact of Obesity on Vaccination to SARS-CoV-2
por: Nasr, Michaella-Jana C., et al.
Publicado: (2022)

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses
por: Coronado, Mônika A., et al.
Publicado: (2023)

The IMPORTance of the Nucleus during Flavivirus Replication
por: Lopez-Denman, Adam J., et al.
Publicado: (2017)

The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model
por: Dickson, Alexandria, et al.
Publicado: (2023)

mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
por: Hassert, Mariah, et al.
Publicado: (2020)

Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development
por: Wu, Bingan, et al.
Publicado: (2023)

Historical Perspectives on Flavivirus Research
por: Holbrook, Michael R.
Publicado: (2017)

Memory T Cells in Flavivirus Vaccination
por: Li, Guangyu, et al.
Publicado: (2018)

Bioinformatics in New Generation Flavivirus Vaccines
por: Koraka, Penelope, et al.
Publicado: (2010)

Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination
por: Stone, E. Taylor, et al.
Publicado: (2022)

Research advancements in the neurological presentation of flaviviruses
por: Chen, Tingting, et al.
Publicado: (2018)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

Mosquito-Borne Flaviviruses and Current Therapeutic Advances
por: Qian, Xijing, et al.
Publicado: (2022)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Current Advances and Future Prospects for Molecular Research for Agronomically Important Traits in Rice
por: Hori, Kiyosumi, et al.
Publicado: (2022)

Flaviviruses
Publicado: (2005)

Characterization of Three New Insect-Specific Flaviviruses: Their Relationship to the Mosquito-Borne Flavivirus Pathogens
por: Guzman, Hilda, et al.
Publicado: (2018)

Development of Antibody Therapeutics against Flaviviruses
por: Sun, Haiyan, et al.
Publicado: (2017)

Flavivirus: From Structure to Therapeutics Development
por: Zhao, Rong, et al.
Publicado: (2021)

Immune response to arbovirus infection in obesity
por: Hameed, Muddassar, et al.
Publicado: (2022)

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
por: Li, Xiao-Feng, et al.
Publicado: (2018)

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination
por: Kaaijk, Patricia, et al.
Publicado: (2017)

Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses
por: Harrison, Jessica J., et al.
Publicado: (2021)

Mucosal Vaccination: A Promising Alternative Against Flaviviruses
por: Luria-Pérez, Rosendo, et al.
Publicado: (2022)

Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
por: Taslem Mourosi, Jarin, et al.
Publicado: (2022)

The Importance of Cardiology Research
por: Somberg, John
Publicado: (2020)

The importance of crafting a good introduction to scholarly research: strategies for creating an effective and impactful opening statement
por: Tavakol, Mohsen, et al.
Publicado: (2023)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5r0lfs6fovbf1g5dgpat0b664u